Summary
We measured the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 (VLDL apoB) using a stable isotope gas-chromatography mass-spectrometry method in six patients with non-insulin-dependent diabetes mellitus (NIDDM) (four males, two females, age 57.5±2.2 years (mean±SEM), weight 88.2±5.5 kg, glycated haemoglobin (HbA1) 8.5±0.5%, plasma total cholesterol concentration 5.7±0.5 mmol/l, triglyceride 3.8±0.9 mmol/l, high-density lipoprotein (HDL) cholesterol 1.0±0.1 mmol/l) and six non-diabetic subjects matched for age, sex and weight (four males, two females, age 55.7±2.8 years, weight 85.8±5.6 kg, HbA1 6.5±0.1%, plasma total cholesterol concentration 5.7±0.5 mmol/l, triglyceride 1.2±0.1 mmol/l, HDL cholesterol 1.4±0.1 mmol/l). HbA1, plasma triglyceride and mevalpnic acid (an index of cholesterol synthesis in vivo) concentrations were significantly higher in the diabetic patients than in the non-diabetic subjects (p=0.006, p=0.02 and p=0.004, respectively). VLDL apoB absolute secretion rate was significantly higher in the diabetic patients compared with the non-diabetic subjects (2297±491 vs 921±115 mg/day, p<0.05), but there was no significant difference in the fractional catabolic rate of VLDL apoB. There was a positive correlation between VLDL apoB secretion rate and (i) fasting C-peptide (r=0.84, p=0.04) and (ii) mevalonic acid concentration (r=0.83, p<0.05) in the diabetic patients but not in the non-diabetic subjects. There was also a significant positive association between plasma mevalonic acid and plasma C-peptide (r=0.82, p<0.05) concentrations in the diabetic patients. We conclude that in NIDDM, there is increased hepatic secretion of VLDL apoB which may partly explain the dyslipoproteinaemia seen in this condition. We suggest that increased secretion of this apolipoprotein may be a consequence of resistance to the inhibitory effect of insulin on VLDL apoB secretion. Insulin resistance may also be the mechanism by which cholesterol synthesis, a regulator of apoB secretion, is increased in NIDDM.
Article PDF
Similar content being viewed by others
Abbreviations
- ApoB:
-
Apolipoprotein B-100
- VLDL:
-
very-low-density lipoprotein
- GCMS:
-
gas-chromatography mass-spectrometry
- MVA:
-
mevalonic acid
- Hep G2:
-
hepatoma G2
- α-KIC:
-
α-ketoisocaproic acid
- TC:
-
total cholesterol
- TG:
-
triglyceride
- NEFA:
-
non-esterified fatty acids
- FSR:
-
fractional secretion rate
- ASR:
-
absolute secretion rate
- m/z:
-
mass to charge ratio
- CV:
-
coefficient of variation
References
Jarrett J (1990) Mortality in diabetes. Quart J Med 75: 413–414
Merrin PK, Feher MD, Elkeles RS (1992) Diabetic macrovascular disease and serum lipids: is there a connection? Diabet Med 9: 9–14
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595–1607
Olefsky JM, Farquhar JW, Reaven GM (1974) Reappraisal of the role of insulin in hypertriglyceridaemia. Am J Med 57: 551–560
Reaven GM, Greenfield MS (1981) Diabetic hypertriglyceridaemia. Evidence for three clinical syndromes. Diabetes 30: 66–75
Vogelberg KH, Gries FA, Moschinski D (1980) Hepatic production of very-low-density lipoprotein triglyceride. Dependence of portal substrate and insulin concentration. Horm Metab Res 12: 688–694
Pietri AO, Dunn FL, Grundy SM, Raskin P (1983) The effect of continuous subcutaneous insulin infusion on very-low-density lipoprotein triglyceride metabolism in type 1 diabetes mellitus. Diabetes 32: 75–81
Gibbons GF (1986) Hyperlipidaemia of diabetes. Clin Sci 171: 477–486
Gibbons GF (1990) Assembly and secretion of hepatic very-low-density lipoprotein. Biochem J 268: 1–13
Ginsberg HN (1987) Very low density lipoprotein metabolism in diabetes mellitus. Diabetes/Metab Rev 3: 571–589
Sparks JD, Sparks CE (1990) Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J Biol Chem 265: 8854–8862
Jackson TK, Salhanick AI, Elovson J, Deichman ML, Amatruda JM (1990) Insulin regulates apolipoprotein turnover and phosphorylation in rat hepatocytes. J Clin Invest 86: 1746–1751
Lewis GF, Uffelman KD, Szeto LW, Steiner G (1993) Effects of acute hyperinsulinaemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes 42: 833–842
Howard BV (1987) Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28: 613–628
Kissebah AH, Alfarsi S, Evans DJ, Adams PW (1982) Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin dependent diabetes mellitus. Diabetes 31: 217–225
Taskinen M-R, Packard CJ, Shepherd J (1990) Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM. Diabetes 39: 1017–1027
Taskinen M-R, Beltz WF, Harper I et al. (1986) Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapy. Diabetes 35: 1268–1277
Howard BV, Abbott WGH, Beltz WF et al. (1987) Integrated study of low-density lipoprotein metabolism and very-low-density-lipoprotein metabolism in non-insulin-dependent diabetes. Metabolism 36: 870–877
Beltz WF, Kesaniemi YA, Miller NH, Fisher WR, Grundy SM, Zech LA (1990) Studies on the metabolism of apolipoprotein B in hypertriglyceridaemic subjects using simultaneous administration of tritiated leucine and radio-iodinated very low density lipoprotein. J Lipid Res 31: 361–374
Ramakrishnan R, Arad Y, Wong S, Ginsberg HN (1990) Nonuniform radiolabelling of VLDL apolipoprotein B: implications for the analysis of studies of the kinetics of the metabolism of lipoproteins containing apolipoprotein B. J Lipid Res 31: 1031–1042
Parhofer KF, Barrett PHR, Bier DM, Schonfeld G (1991) Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes J Lipid Res 32: 1311–1323
Scoppola A, Maher VMG, Thompson GR, Rendell NB, Taylor GW (1991) Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry. J Lipid Res 32: 1057–1060
Parker TS, Mcnamara DJ, Brown CD et al. (1984) Plasma mevalonate as a measure of cholesterol biosynthesis in man. J Clin Invest 74: 795–804
Khan BK, Wilcox HG, Heimberg M (1989) Cholesterol is required for secretion of very-low-density lipoprotein by rat liver. Biochem J 259: 807–816
Naoumova RP, Cummings MH, Watts GF, Thompson GR (1994) Direct correlation between in vivo cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidaemic subjects. Atherosclerosis 109: 102–103 (Abstract)
Ginsberg HN, Le N-A, Short M, Ramakrishnan R, Desnick RJ (1987) Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. J Clin Invest 80: 1692–1697
Cummings MH, Watts GF (1995) Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in cholesterol ester storage disease. Clin Chem 41: 111–114
Cianflone K, Yasruel Z, Rodriguez MA, Vas D, Sniderman AD (1990) Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J Lipid Res 31: 2045–2054
Cohn JS, Wagner DA, Cohn SD, Millar JS, Schaefer EJ (1990) Measurement of very low density and low density lipoprotein apolipoprotein (apo) B-100 and high density lipoprotein apo A-1 production in human subjects using deuterated leucine. Effects of feeding and fasting. J Clin Invest 85: 804–811
Bogardus C, Lillioja S, Howard BV, Reaven GM, Mott D (1984) Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in non-diabetic and non insulin dependent diabetic subjects. J Clin Invest 74: 1238–1246
Matthews D E, Schwartz HP, Yand RD, Motil KJ, Young VR, Bier DM (1982) Relationship of plasma leucine and alpha-ketoisocaproate during a L-[1-13C]leucine infusion in man: a method for measuring human intracellular leucine tracer enrichment. Metabolism 31: 1105–1112
Cummings MH, Watts GF, Umpleby M, Hennessy TR, Quiney JR, Sonksen PH (1995) Increased hepatic secretion of very-low-density lipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study. Atherosclerosis 113: 79–89
Kane JP, Sata T, Hamilton RL (1975) Apoprotein composition of very low density lipoproteins of human serum. J Clin Invest 56: 1622–1634
Venkatesan S, Cullen P, Halliday D, Scott J (1993) Stable isotopes show a direct relation between VLDL apoB over-production and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidaemia. Arteriosclerosis Thrombosis 13: 1110–1118
Cobelli C, Toffolo G, Foster DM (1992) Tracer-to-tracee ratio for analysis of stable isotope tracer data: link with radioactive kinetic formalism. Am J Physiol 262:E968-E975
Cummings MH, Watts GF, Lumb PJ, Slavin BM (1994) Comparison of immunoturbidimetric and Lowry methods for measuring concentration of very low density lipoprotein apolipoprotein B-100 in plasma. J Clin Path 47: 176–178
Pfohl M, Naoumova RP, Klass C et al. (1994) Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG-CoA reductase inhibitor therapy. J Lipid Res 35(11):1946–1955
Davignon J, Gregg RE, Sing SF (1988) Apolipoprotein E polymorphisms and atherosclerosis. Arteriosclerosis 8: 1–21
Foster DM, Barrett PHR, Toffolo G, Beltz WF, Cobelli C (1993) Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data. J Lipid Res 34: 2193–2205
ICSH (1980) Recommended methods of measurement of red-cell and plasma volume. J Nuclear Med 21: 793–812
Altman DG (1992) Comparing groups — continuous data. In: Altman (ed) Practical statistics for medical research. Chapman and Hall, London Glasgow New York Tokyo Melbourne Madras, pp179–228
Cummings MH, Watts GF, Pal C et al. (1995) Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein-B100 in obesity: a stable isotope study. Clin Sci 88: 225–233
Arends J, Bier DM, Schafer G et al. (1993) No evidence for feedback inhibition of hepatic apolipoprotein B (apoB) production after extracorporeal low density lipoprotein precipitation by [1-13C]leucine infusion in normal volunteers. Eur J Clin Invest 23: 602–614
Layman DK, Wolfe RR (1987) Sample site selection for tracer studies applying a unidirectional circulatory approach. Am J Physiol 253:E173-E178
Pacy PJ, Venkatesan S, Bannister P, Millward DJ, Halliday D (1991) Is plasma 13C-α-ketoisocaproic acid representative of the hepatic precursor pool? Clin Sci 80: 20 (Abstract)
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
Dashti N (1992) The effect of low-density-lipoprotein cholesterol and 25-hydroxy cholesterol in apolipoprotein B gene expression in Hep G2 gene cells. J Biol Chem 267: 7160–7169
Kesaniemi YA, Ehnholm C, Miettinen TA (1987) Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 80: 578–581
Tomkin GH, Owens D (1991) Abnormalities of cholesterol metabolism in diabetes. Proc Nutr Soc 50: 583–589
Stinson JC, Owens D, Collins P, Johnson A, Tomkin GH (1993) Hyperinsulinaemia is associated with stimulation of cholesterol synthesis in both type 1 and type 2 diabetes. Diabet Med 10: 412–419
Wu X, Sakata N, Dixon J, Ginsberg HN (1994) Exogenous VLDL stimulates apolipoprotein B secretion from HepG2 cells by both pre- and post-translational mechanisms. J Lipid Res 35: 1200–1210
Kissebah AH, Alfarsi S, Adams PW, Wynn V (1976) Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia 12: 563–571
Durrington PN (1992) Is insulin atherogenic ? Diabet Med 9: 597–600
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cummings, M.H., Watts, G.F., Umpleby, A.M. et al. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetologia 38, 959–967 (1995). https://doi.org/10.1007/BF00400586
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400586